Gabapentin Tablet, Coated
Product Images NDC 71335-1287
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71335-1287). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Gabapentin 02)
The text shows a chart where the mean pain score is evaluated during a clinical trial that included a 4-week dose titration period and a 4-week fixed dose period. The chart compares the effects of placebo versus gabapentin at a dosage of 3,600 mg/day. The chart shows the mean pain score for each week of the study, identified as Baseline, 1, 2, 3, 4, 5, 6, 7, and 8.*
Figure 2 (Gabapentin 03)
Figure 3 (Gabapentin 04)
This appears to be a chart or graph showing percentages related to two different studies. The first study has a success rate of 100%, while the second study has a success rate of 90% with a statistical significance level of 0.001. There are percentages displayed for 80%, 70%, and 60%, but it is unclear what they represent without further context. The bottom of the chart lists three different values for PBO, GBP, and 3,600, 1,800, and 2,400, respectively. It is not clear what these values refer to without further information.*
Figure 4 (Gabapentin 05)
Label Image (Lbl713351287)
This is a medication package of Neurontin 600mg Tablets, packaged by Bryant Ranck Prepack, which is to be compared with CSPC Ouyi Pharmaceutical Co. Ltd. The package contains 30 tablets and should be stored at room temperature between 20°-25°C (68°-77°F). The NDC number for this package is 7133512871, and the expiration date is not provided. The package also includes a caution to keep all drugs out of reach of children.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.